Alteration in the frequency, severity and duration of chemotherapy-induced mucositis in hamsters by interleukin-11

European Journal of Cancer. Part B: Oral Oncology

Volumn 31, Issue 4, 1995, Pages 261-266

  Sonis, S ^a,b   Muska, A ^a   O'Brien, J ^a   VanVugt, A ^a   Langer Safer, P ^c   Keith, J ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^c PFIZER INC   (United States)

Author keywords

animal model; chemotherapy; hamster; interleukin 11; mucositis

Indexed keywords

FLUOROURACIL; RECOMBINANT INTERLEUKIN 11;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HAMSTER; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MUCOSA INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMAL; ANTIMETABOLITES, ANTINEOPLASTIC; BONE MARROW; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOROURACIL; HAMSTERS; INTERLEUKIN-11; MALE; MESOCRICETUS; MOUTH MUCOSA; PLATELET COUNT; RECOMBINANT PROTEINS; STOMATITIS; SUPPORT, NON-U.S. GOV'T; SURVIVAL RATE; WEIGHT LOSS;

EID: 0029086770     PISSN: 09641955     EISSN: None     Source Type: Journal    
DOI: 10.1016/0964-1955(95)00015-A     Document Type: Article

References (26)

1. Gastrointestinal toxicity of chemotherapeutic agents
2. Oral toxicity of chemotherapeutic agents
3. Prevention and management of oral mucositis induced by antineoplastic therapy
4. Long-term, ambulatory continuous iv infusion of 5-FU for the treatment of advanced adenocarcinomas
5. Remission induction of meningeal leukemia with high-dose intravenous methotrexate
6. Methotrexate, vinblastine, doxorubicin, and cisplatin in metastatic breast cancer
7. An effective therapy for both undifferentiated (including Burkitt's) lymphoma and lymphoblastic lymphomas in children and young adults
8. A phase I–II study of cytosine arabinoside, daunorubicin, and VP16–213 in adult patients with acute non-lymphocytic leukemia
9. Acute mucocutaneous toxicity following high-dose hydroxyurea
10. Dual modulation of 5-fluorouracil using leucovorin and hydroxyurea
11. Oral manifestations and fever in immunocompromised patients with haematologic malignancies
12. Failure of clindamycin to influence the course of severe oromucositis associated with streptococcal bacteraemia in allogeneic bone marrow transplant recipients
13. Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium
14. Prevention of chemotherapy-induced ulcerative mucositis by transforming growth factor beta-3
15. Molecular cloning of cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic cytokine
16. Interleukin-11 an inducible cytokine in human articular chondrocytes and synoviocytes, stimulates the production of the tissue inhibitor of metalloproteinases
17. Interleukin-11: a multifunctional growth factor derived from the hematopoietic microenvironment
18. Measurement of human Interleukin-11
19. An animal model for mucositis induced by cancer chemotherapy
20. Effect of epidermal growth factor on ulcerative mucositis in hamsters that receive cancer chemotherapy
21. Mucosal alterations
22. A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients
23. Oral complications of cancer chemotherapy in pediatric patients
24. Effect of granulocytemacrophage colony-stimulating factor (GMCSF) on oral mucositis after autologous bone marrow transplantation (Meeting abstract)
25. The biology of interleukin 11
26. A bone marrow-stromal-derived growth factor, interleukin-11, stimulates recovery of small intestinal mucosal cells after cytoablative therapy